Variant report
Variant | esv3372556 |
---|---|
Chromosome Location | chr6:161087762-161092360 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:214)
- CpG islands (count:122)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:161088755-161088805 | SAEC | small airway: | n/a |
2 | chr6:161088755-161088805 | AG09319 | gingival: | n/a |
3 | chr6:161088246-161088296 | AG09319 | gingival: | n/a |
4 | chr6:161088246-161088296 | PrEC | prostate: | n/a |
5 | chr6:161088755-161088805 | MCF-7 | breast: | n/a |
6 | chr6:161088246-161088296 | SK-N-SH | brain: | n/a |
7 | chr6:161088246-161088296 | HEEpiC | esophagus: | n/a |
8 | chr6:161088246-161088296 | SAEC | small airway: | n/a |
9 | chr6:161088755-161088805 | IMR90 | lung: | fetal |
10 | chr6:161088246-161088296 | BE2_C | brain: | n/a |
11 | chr6:161088755-161088805 | AoSMC | blood vessel: | n/a |
12 | chr6:161088755-161088805 | NH-A | brain: | n/a |
13 | chr6:161088246-161088296 | MCF10A-Er-Src | breast: | n/a |
14 | chr6:161088755-161088805 | HMEC | breast: | n/a |
15 | chr6:161088246-161088296 | H1-hESC | embryonic stem cell: | embryo |
16 | chr6:161088755-161088805 | HCPEpiC | choroid plexus: | n/a |
17 | chr6:161088755-161088805 | GM12878 | blood: | n/a |
18 | chr6:161088246-161088296 | GM19239 | blood: | n/a |
19 | chr6:161088246-161088296 | GM12891 | blood: | n/a |
20 | chr6:161088755-161088805 | ProgFib | skin: | n/a |
21 | chr6:161088755-161088805 | Hela-S3 | cervix: | n/a |
22 | chr6:161088755-161088805 | ECC-1 | luminal epithelium: | n/a |
23 | chr6:161088755-161088805 | H1-hESC | embryonic stem cell: | embryo |
24 | chr6:161088246-161088296 | HRPEpiC | eye: | n/a |
25 | chr6:161088246-161088296 | HAEpiC | amniotic membrane: | n/a |
26 | chr6:161088246-161088296 | SKMC | muscle: | n/a |
27 | chr6:161088755-161088805 | HCF | heart: | n/a |
28 | chr6:161088246-161088296 | ProgFib | skin: | n/a |
29 | chr6:161088246-161088296 | NB4 | blood: | n/a |
30 | chr6:161088755-161088805 | GM12892 | blood: | n/a |
31 | chr6:161088755-161088805 | HRCEpiC | kidney: | n/a |
32 | chr6:161088755-161088805 | AG04450 | lung: | fetal |
33 | chr6:161088755-161088805 | NHDF-neo | bronchial: | n/a |
34 | chr6:161088246-161088296 | IMR90 | lung: | fetal |
35 | chr6:161088755-161088805 | NHBE | bronchial: | n/a |
36 | chr6:161088755-161088805 | PFSK-1 | brain: | n/a |
37 | chr6:161088755-161088805 | Hepatocyte | liver: | n/a |
38 | chr6:161088755-161088805 | HCT-116 | colon: | n/a |
39 | chr6:161088246-161088296 | HL-60 | blood: | n/a |
40 | chr6:161088246-161088296 | Caco-2 | colon: | n/a |
41 | chr6:161088755-161088805 | HepG2 | liver: | n/a |
42 | chr6:161088755-161088805 | HCM | heart: | n/a |
43 | chr6:161088246-161088296 | HIPEpiC | eye: | n/a |
44 | chr6:161088755-161088805 | HIPEpiC | eye: | n/a |
45 | chr6:161088755-161088805 | HPAEpiC | pulmonary alveolar: | n/a |
46 | chr6:161088246-161088296 | HNPCEpiC | eye: | n/a |
47 | chr6:161088246-161088296 | GM12892 | blood: | n/a |
48 | chr6:161088246-161088296 | LNCaP | prostate: | n/a |
49 | chr6:161088246-161088296 | CMK | blood: | n/a |
50 | chr6:161088755-161088805 | HEEpiC | esophagus: | n/a |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:160939583..160942817-chr6:161087432..161090286,3 | K562 | blood: | |
2 | chr6:160940535..160941592-chr6:161088101..161089900,7 | K562 | blood: | |
3 | chr6:160876814..160877519-chr6:161088556..161089198,2 | MCF-7 | breast: | |
4 | chr6:160941041..160942817-chr6:161087432..161089515,2 | K562 | blood: | |
5 | chr6:160940670..160941542-chr6:161088487..161089076,2 | MCF-7 | breast: | |
6 | chr6:160954972..160955719-chr6:161088699..161089595,2 | MCF-7 | breast: | |
7 | chr6:160876729..160877411-chr6:161088842..161089583,2 | K562 | blood: | |
8 | chr6:161080728..161083245-chr6:161087740..161089889,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
LPA | TF binding region |
LPA | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552479297 | chr6:161087812-161087813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569034178 | chr6:161087836-161087837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531357822 | chr6:161087837-161087838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577086890 | chr6:161087841-161087842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568166067 | chr6:161087847-161087848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs41269133 | chr6:161087863-161087864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs783148 | chr6:161087869-161087870 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs185904768 | chr6:161087908-161087909 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs539626336 | chr6:161087970-161087971 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs41269131 | chr6:161088015-161088016 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs149570306 | chr6:161088027-161088028 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs556840151 | chr6:161088044-161088045 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs370286303 | chr6:161088069-161088070 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs144246165 | chr6:161088070-161088071 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs190367591 | chr6:161088100-161088101 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs371159825 | chr6:161088105-161088106 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs111327256 | chr6:161088135-161088136 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs182575854 | chr6:161088202-161088203 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs573009233 | chr6:161088218-161088219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187573114 | chr6:161088219-161088220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564408949 | chr6:161088247-161088248 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs140783135 | chr6:161088250-161088251 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs562208600 | chr6:161088252-161088253 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs375400267 | chr6:161088261-161088262 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs545651209 | chr6:161088264-161088265 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs562811805 | chr6:161088266-161088267 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs190484092 | chr6:161088284-161088285 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs548500262 | chr6:161088325-161088326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144731944 | chr6:161088330-161088331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527264284 | chr6:161088348-161088349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547546943 | chr6:161088358-161088359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs17557261 | chr6:161088399-161088400 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs540041615 | chr6:161088400-161088401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147603287 | chr6:161088411-161088412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs115227831 | chr6:161088417-161088418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs113585105 | chr6:161088422-161088423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183904052 | chr6:161088539-161088540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189242308 | chr6:161088545-161088546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561443884 | chr6:161088548-161088549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555629057 | chr6:161088617-161088618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs76214705 | chr6:161088643-161088644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534675790 | chr6:161088684-161088685 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs142210658 | chr6:161088707-161088708 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs578008201 | chr6:161088727-161088728 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs544578826 | chr6:161088756-161088757 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs545983399 | chr6:161088836-161088837 | Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs562589559 | chr6:161088858-161088859 | Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs783149 | chr6:161088918-161088919 | Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs75274517 | chr6:161088956-161088957 | Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs573301366 | chr6:161088982-161088983 | Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chordoma | 18071362 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:161084200-161089800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr6:161087200-161088600 | Weak transcription | Liver | Liver |
3 | chr6:161087400-161089600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
4 | chr6:161087600-161100200 | Weak transcription | Right Atrium | heart |
5 | chr6:161088600-161089400 | Enhancers | Liver | Liver |
6 | chr6:161088800-161089000 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |
7 | chr6:161088800-161089000 | Flanking Bivalent TSS/Enh | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:161088800-161089000 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
9 | chr6:161089400-161089800 | Weak transcription | Liver | Liver |
10 | chr6:161089600-161090000 | ZNF genes & repeats | H9 Cell Line | embryonic stem cell |
11 | chr6:161089600-161090200 | ZNF genes & repeats | Fetal Adrenal Gland | Adrenal Gland |
12 | chr6:161089800-161090200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr6:161089800-161090200 | Bivalent/Poised TSS | Breast Myoepithelial Primary Cells | Breast |
14 | chr6:161089800-161090200 | Active TSS | Fetal Kidney | kidney |
15 | chr6:161089800-161091000 | Strong transcription | Liver | Liver |
16 | chr6:161090200-161090800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
17 | chr6:161090800-161091400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
18 | chr6:161091000-161098200 | Weak transcription | Liver | Liver |
19 | chr6:161091400-161092200 | Flanking Active TSS | Fetal Adrenal Gland | Adrenal Gland |
20 | chr6:161092200-161092600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |